Acessibilidade / Reportar erro

Acral persistent papular mucinosis with pruritic skin lesions* * Work conducted at the Hospital Universitari Sagrat Cor, Barcelona, Spain.

Dear Editor,

Cutaneous mucinoses are a group of diseases in which there is an abnormal deposit of mucin in the skin. It can be classified into primary and secondary forms. An uncommon subtype of primary mucinosis, acral persistent papular mucinosis (APPM) is currently considered as a clinicopathological variant of lichen myxedematosus.

A 31-year-old woman presented a 10-year history of persistent pruritic lesions on her arms. She had no relevant medical history. Physical examination revealed multiple, non-follicular and small (2-5 mm) skin-colored papules, some of them translucent, on the dorsum of both forearms (Figure 1). There were no other similar lesions on the rest of the body. The patient reported that topical corticosteroids were ineffective and sun exposure increased the number of lesions. Laboratory studies were within normal range, including blood cell count, liver, kidney and thyroid function. Antinuclear antibodies were negative. Skin punch biopsy of a papule was performed and histopathological examination showed no alteration in the epidermis. There was a focal area in the upper and mid reticular dermis due to a separation of collagen fibers. Deposit of mucin in the papillary dermis that stained positively with alcian blue was observed. There was no deposit of mucin in the reticular dermis. Fibroblast proliferation was not evident (Figure 2). APPM was then diagnosed.

Figure 1
Small skin-colored papules, some of them translucent, symmetrically located on the dorsum of both forearms

Figure 2
Epidermis shows no alterations. Note the focal area in the upper and mid reticular dermis due to a separation of collagen fibers. The area is positively stained with alcian blue, indicating deposit of mucin (Alcian blue, x40)

APPM was first described by Rongioletti et al. in 198611 Rongioletti F, Rebora A, Crovato F. Acral persistent papular mucinosis: a new entity. Arch Dermatol. 1986;122:1237-9. and the etiology is unknown, although both genetic and environmental factors are thought to play a role. Rongioletti and Rebora in 2001 proposed several diagnostic criteria for APPM and, to date, there have been more than 30 reported cases of this entity that met the criteria (Table 1).22 Pérez-Mies B, Hernández-Martín A, Barahona-Cordero E, Echevarría-Iturbe C. Mucinosis Papular Acral Persistente. Actas Dermosifiliogr. 2006;97:522-4. Three cases showed family history.33 Jun JY, Oh SH, Shim JH, Kim JH, Park JH, Lee DY. Acral Persistent Papular Mucinosis with Partial Response to Tacrolimus Ointment. Ann Dermatol. 2016;28:517-9. Clinically, it is characterized by small flesh-colored, papules that most often are symmetrically localized on the back of the hands, wrists and extensor aspects of distal forearms. Differential diagnosis includes lichen nitidus, common warts and other forms of mucinosis. The lesions are usually asymptomatic, although in our case they were very pruritic. They tend to persist and may increase slowly. There is a female predominance. Neither systemic disease nor monoclonal gammopathy in peripheral blood are observed in this entity. The possible association with malignancies has not been clarified yet.44 Gómez Sánchez ME, Manueles Marcos F, Martínez Martínez ML, Vera Berón R, Azaña Défez JM. Acral papular mucinosis. A new case of this rare entity. An Bras Dermatol. 2016;91:111-3. The typical histopathology of APPM is a focal, well-circumscribed deposit of mucin in the papillary and mid-dermis. The deposit never extends to the deep reticular dermis. Fibroblastic proliferation is variable, although normally they are not increased in number. Due to the absence of symptoms, treatment is rarely necessary. APPM has been treated with topical corticosteroids, tacrolimus, pimecrolimus, liquid nitrogen, electrocoagulation and Erbium-YAG laser with some success.55 Graves MS, Lloyd AA, Ross EV. Treatment of acral persistent papular mucinosis using an Erbium-YAG laser. Lasers Surg Med. 2015;47:467-8. In our case, the patient reported pruritus, so we treated with topical 0.1% tacrolimus ointment for five weeks, but it was ineffective. We prescribed a fluid emulsion 12% sodium lactate for two months and the symptoms disappeared. We herein present a new case of this rare mucinosis. It is important to know that most cases are asymptomatic, but in our case, the patient presented pruritic lesions.

Table 1.
Diagnostic criteria for APPM
  • *
    Work conducted at the Hospital Universitari Sagrat Cor, Barcelona, Spain.
  • Financial support: None.

REFERENCES

  • 1
    Rongioletti F, Rebora A, Crovato F. Acral persistent papular mucinosis: a new entity. Arch Dermatol. 1986;122:1237-9.
  • 2
    Pérez-Mies B, Hernández-Martín A, Barahona-Cordero E, Echevarría-Iturbe C. Mucinosis Papular Acral Persistente. Actas Dermosifiliogr. 2006;97:522-4.
  • 3
    Jun JY, Oh SH, Shim JH, Kim JH, Park JH, Lee DY. Acral Persistent Papular Mucinosis with Partial Response to Tacrolimus Ointment. Ann Dermatol. 2016;28:517-9.
  • 4
    Gómez Sánchez ME, Manueles Marcos F, Martínez Martínez ML, Vera Berón R, Azaña Défez JM. Acral papular mucinosis. A new case of this rare entity. An Bras Dermatol. 2016;91:111-3.
  • 5
    Graves MS, Lloyd AA, Ross EV. Treatment of acral persistent papular mucinosis using an Erbium-YAG laser. Lasers Surg Med. 2015;47:467-8.

Publication Dates

  • Publication in this collection
    Sep-Oct 2018

History

  • Received
    18 Nov 2017
  • Accepted
    01 Feb 2018
Sociedade Brasileira de Dermatologia Av. Rio Branco, 39 18. and., 20090-003 Rio de Janeiro RJ, Tel./Fax: +55 21 2253-6747 - Rio de Janeiro - RJ - Brazil
E-mail: revista@sbd.org.br